Search Results Search Sort by RelevanceMost Recent State of the Art and Science May 2016 International Access to Clinical Ethics Consultation via Telemedicine Katrina A. Bramstedt, PhD, MA Telemedicine is fast becoming a reliable medium for convening ethics deliberations and bringing expert assistance to remote locations. AMA J Ethics. 2016;18(5):521-527. doi: 10.1001/journalofethics.2016.18.5.stas2-1605. Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Viewpoint May 2008 The Teaching of Law in Medical Education Nirav D. Shah, JD Virtual Mentor. 2008;10(5):332-337. doi: 10.1001/virtualmentor.2008.10.5.oped1-0805. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Case and Commentary Feb 2020 How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs? Paul Ndebele, PhD and Sithembile Ruzario, MSc Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake. AMA J Ethics. 2020;22(2):E76-81. doi: 10.1001/amajethics.2020.76. Case and Commentary Mar 2016 Ethical Challenges for the Medical Expert Witness Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Medical expert witnesses are ethically and legally obligated to provide honest testimony that meets the standards of the Daubert test. AMA J Ethics. 2016;18(3):201-208. doi: 10.1001/journalofethics.2016.18.3.ecas1-1603. Viewpoint Nov 2002 Cultural Differences Intensify End-of-life Care Challenges Linda MacDonald Glenn, LLM and Faith Lagay, PhD Virtual Mentor. 2002;4(11):341-344. doi: 10.1001/virtualmentor.2002.4.11.elce1-0211. Medical Education Oct 2002 Cultural Impasse Akshara Meran Virtual Mentor. 2002;4(10):305-307. doi: 10.1001/virtualmentor.2002.4.10.puhl1-0210. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Next page Next › Last page Last »
State of the Art and Science May 2016 International Access to Clinical Ethics Consultation via Telemedicine Katrina A. Bramstedt, PhD, MA Telemedicine is fast becoming a reliable medium for convening ethics deliberations and bringing expert assistance to remote locations. AMA J Ethics. 2016;18(5):521-527. doi: 10.1001/journalofethics.2016.18.5.stas2-1605.
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Viewpoint May 2008 The Teaching of Law in Medical Education Nirav D. Shah, JD Virtual Mentor. 2008;10(5):332-337. doi: 10.1001/virtualmentor.2008.10.5.oped1-0805.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Case and Commentary Feb 2020 How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs? Paul Ndebele, PhD and Sithembile Ruzario, MSc Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake. AMA J Ethics. 2020;22(2):E76-81. doi: 10.1001/amajethics.2020.76.
Case and Commentary Mar 2016 Ethical Challenges for the Medical Expert Witness Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Medical expert witnesses are ethically and legally obligated to provide honest testimony that meets the standards of the Daubert test. AMA J Ethics. 2016;18(3):201-208. doi: 10.1001/journalofethics.2016.18.3.ecas1-1603.
Viewpoint Nov 2002 Cultural Differences Intensify End-of-life Care Challenges Linda MacDonald Glenn, LLM and Faith Lagay, PhD Virtual Mentor. 2002;4(11):341-344. doi: 10.1001/virtualmentor.2002.4.11.elce1-0211.
Medical Education Oct 2002 Cultural Impasse Akshara Meran Virtual Mentor. 2002;4(10):305-307. doi: 10.1001/virtualmentor.2002.4.10.puhl1-0210.